skip to the content

Growth and survival of tumour blood vessels

image here
Hicklin DJ, Ellis LM. J Clin Oncol 2005;23:1011–27. Reprinted with permission from the American Society of Clinical Oncology.

The role of VEGF in tumour angiogenesis

This image shows the many effects of the family of VEGF and VEGFRs in tumour angiogenesis. VEGF stimulation of VEGFR-1 and VEGFR-2 on endothelial cells induces endothelial cell proliferation, migration and survival, as well as vascular permeability – all effects that lead to tumour angiogenesis. VEGF may also recruit endothelial progenitor cells and VEGFR-1-expressing myeloid cells to sites of tumour neovascularisation. Finally, VEGF-C and VEGF-D interact with VEGFR-3 on the surface of lymphatic endothelial cells, leading to lymphangiogenesis.4

 

VEGF stimulates tumour angiogenesis

The binding of VEGF to receptors on endothelial cells initiates the creation of a vascular network, allowing tumours access to the oxygen and nutrients they need to grow and metastasise.4

 

VEGF is a survival factor for existing tumour vasculature

Endothelial cells require VEGF for their continued survival in immature blood vessels.64,65 In the absence of growth signals, endothelial cells undergo programmed cell death (apoptosis). Upon pericyte association with vascular endothelial cells (vascular maturation), VEGF is no longer required for survival.4,66